Phase 4 Macular Degeneration Clinical Trials
10 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–10 of 10 trials
Recruiting
Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Genentech, Inc.188 enrolled50 locationsNCT04853251
Recruiting
Phase 4
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration
Geographic AtrophyAge-Related Macular Degeneration
Astellas Pharma Inc20 enrolled16 locationsNCT06970665
Recruiting
Phase 4
Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration
Macular Degeneration Choroidal Neovascularization
Hospital Authority, Hong Kong40 enrolled1 locationNCT06742307
Recruiting
Phase 4
Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting
Exudative Macular Degeneration
Medical University of Vienna290 enrolled1 locationNCT05093374
Recruiting
Phase 4
Switching to Aflibercept 8mg in Patients Showing Limited Response to Previous Treatment
Age-related Macular Degeneration (ARMD)
Kim's Eye Hospital40 enrolled1 locationNCT06683950
Not Yet Recruiting
Phase 4
Assessing the Efficacy and Durability of Faricimab in Patients Currently Treated for Neovascular Age-Related Macular Degeneration.
Neovascular Age-related Macular Degeneration
CUREOS150 enrolled1 locationACTRN12623000215628
Withdrawn
Phase 4
The brolucizumab anti-vascular endothelial growth factor (anti-VEGF) treatment of Age-Related Macular Degeneration (AMD) Switch Study,
wet age related macular degeneration
Clinical Professor Nitin Verma50 enrolled1 locationACTRN12621000624886
Completed
Phase 3Phase 4
Intravitreal dexamethasone for resistant wet-AMD
Wet aged macular degenerationResistent choroidal neovascularization
A.O.U. Sassari20 enrolled1 locationACTRN12618001102268
Not Yet Recruiting
Phase 3Phase 4
To investigate the role of Intravitreal Aflibercept (Eylea) in the treatment of patients whose wet Age related Macular degeneration is not adequately controlled with conventional anti VEGF (intravitreal Avastin or Lucentis) treatment.
Exudative (Wet) Age related Macular Degeneration
Greenlane Clinical Centre Auckland District Health Board50 enrolled1 locationACTRN12613001020774
Recruiting
Phase 4
Efficacy and safety of verteporfin (Visudyne) in combination with ranibizumab (Lucentis) for the treatment of AMD (Aged-Related Macular Degeneration) (LIV- Lucentis injection with Visudyne).
AMD (Aged-Related Macular Degeneration)
Royal Adelaide Hospital20 enrolled1 locationACTRN12609001051235